Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents

Document Type

Conference Proceeding

Publication Title

Clinical Infectious Diseases

Abstract

We compared rates of recurrent Clostridium difficile infection in patients receiving or not receiving oral vancomycin prophylaxis with systemic antimicrobial therapy. The incidence of C. difficile infection was significantly lower in patients receiving prophylaxis (4.2% vs 26.6% in those without prophylaxis; odds ratio, 0.12; 95% confidence interval,. 04-.4; P <. 001).

First Page

651

Last Page

653

DOI

10.1093/cid/ciw401

Publication Date

9-1-2016

This document is currently not available here.

Share

COinS